SNN Smith & Nephew plc
438
$24.75
$0.03
(0.12%)
| Watchers | 438 |
| 52-Wk Low | $21.53 |
| 52-Wk High | $32.71 |
| Market Cap | $10.79B |
| Volume | 3,972.00 |
| 52-Wk High | $32.71 |
| 52-Wk Low | $21.53 |
Is this the most undervalued FTSE stock?The Motley Fool UK • about 1 month ago
Smith & Nephew (LSE:SN) is a FTSE 100 stalwart. It currently has a market cap of 8.5bn and it's one of the most respected medical device manufacturers around the world. However, things haven't been...
Share to Feed
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a...
We consider oversold' to be where one thinks the selling action on said stock has been unduly harsh, presenting a solid buying opportunity in a quality company!
ITV
What it does: Founded in...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC the world's premier mixed martial...
UFC is an American mixed martial arts promotion company based in Las Vegas, which hosts around 40 fights a year and has more than 700m fans...
StockNews.com upgraded shares of Smith Nephew (NYSE:SNN Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Friday. Separately, Barclays...
Smith Nephew (NYSE:SNN Get Free Report) was upgraded by StockNews.com from a buy rating to a strong-buy rating in a research note issued on...